The leading CRO in the OA field
NBCD is dedicated to clinical drug development, specializing in osteoarthritis. As a science-driven organization, we have several articles published each year in well respected, peer-reviewed journals.
Having worked 30+ years with biomarker development, precision medicine and clinical trials, NBCD has acquired extensive experience within rheumatology and musculoskeletal indications. As the leading CRO in the OA field, we have conducted numerous trials in all clinical phases.
Working closely together with our partners in Sanos Group, we can serve as a one-stop shop for clinical trials in osteoarthritis:
- Sanos Clinic, a network of high-recruiting dedicated research centers
- Studies&Me, a tech-based CRO with a unique recruitment platform and DCT capabilities
- Sanos Supply, a clinical trial supply and packaging facility
As a privately owned and highly specialized organization, we can make swift decisions, leverage cross-functional synergies and quickly adapt to accommodate our clients’ current and future needs.
| August 21, 2022 |
New paper published in Experimental Physiology |
| July 22, 2022 |
New paper published in Frontiers Physiology |
| June 03, 2022 |
NBCD attending EULAR 2022 |
| April 29, 2022 |
Studies&Me becomes a part of Sanos Group |
| April 07, 2022 |
NBCD attending OARSI 2022 |
